GlucoTrack faces Nasdaq delisting over minimum bid price deficiency

GlucoTrack Inc

GlucoTrack Inc

GCTK

0.00
  • GlucoTrack received Nasdaq staff determination May 11, 2026, citing noncompliance with Listing Rule 5550(a)(2) minimum $1 bid price requirement, triggering a delisting decision for its Nasdaq Capital Market securities.
  • Hearing request due by May 18, 2026; a timely request would stay further delisting action while GlucoTrack presents a plan to regain compliance.
  • Nasdaq issued a second notice May 15, 2026, flagging failure to meet Listing Rule 5550(b)(1) $2.5 million minimum stockholders’ equity threshold, creating an additional basis for delisting.
  • Hearings Panel will weigh both deficiencies when deciding continued listing; outcome remains uncertain.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GlucoTrack Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-023889), on May 15, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.